March 17, 2021

Charles Prestigiacomo, MD, created the Advanced Anatomy of the Head and Neck elective, offered to fourth-year students at the UC College of Medicine who are getting ready to match in surgical residencies and begin performing procedures on patients. He and colleagues are seeing how this class is better preparing students to begin their careers with a little more “real-life” practice.

December 21, 2020

New UC research shows a dangerous trend in lung cancer caused by the pandemic.

May 26, 2023

University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.

January 5, 2021

Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.

January 21, 2021

UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.

March 16, 2021

Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.

December 17, 2020

A recent study led by University of Cincinnati Cancer Center researchers shows the impact the pandemic had on lung cancer screening, which experts say could be bad for both screening programs in general and for the overall well-being of patients.

September 29, 2020

By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.

May 19, 2023

The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.

February 7, 2023

The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.